Stanford Cancer Immunotherapy Program
Photos
The Stanford Cancer Immunotherapy Program is dedicated to harnessing the immune system to combat cancer through innovative treatments and delivery mechanisms. The program brings together physician-scientists who are advancing patient-specific vaccines and cell-based therapies to stimulate robust immune responses against various cancer types.
With a history of groundbreaking developments, Stanford has pioneered the use of monoclonal antibodies in cancer therapy and continues to explore new therapeutic agents, including cytokines and combination therapies. Their research efforts focus on creating effective cancer vaccines and cellular immunotherapies to enhance the body's natural defenses against cancer.
Generated from the website